SpaceX Continues Rocket Higher: Six-Month Stock Outlook
Investors are watching SpaceX like a rocket on countdown. This article translates historical IPO patterns into a six-...
This intro covers yearly drawdown trends for total market index funds, helping readers assess risk and anticipate potential downturns.
28,238 articlesInvestors are watching SpaceX like a rocket on countdown. This article translates historical IPO patterns into a six-...
Healthcare megacaps Pfizer and Johnson & Johnson continue to deliver quarterly dividends that can generate reliable i...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
A surprise leadership change jolted Copart’s stock, sparking an intraday drop. This article breaks down the why, what...
Rambus rides AI infrastructure tailwinds but keeps a neutral stance as investors weigh valuation against accelerating...
As UnitedHealth gears up for its July 16 results, traders focus on pricing power and rising cash flow as the main rea...
JPMorgan Chase delivered a record quarterly performance, yet Jamie Dimon cautioned that the current market sprint cou...
Bitcoin trades around the $63,000 mark as it confronts stubborn resistance and tests key support levels. Analysts war...
NVIDIA and Meta Platforms announced a sweeping AI-infrastructure agreement, driving stock moves and reshaping the rac...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...
Albemarle posted a net loss in 2025 but still paid dividends, underscoring the tension between cash flow and earnings...
Hims & Hers Health shares have been hammered, marked by a steep decline over past year. This article breaks down the ...